Yasemin Korkmaz

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Combination Therapy

Randomized Controlled Trial

Mesenchymal Stem Cells

Top Venues

Fundamental & clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Yasemin Korkmaz, Burak Dik
The comparison of the antidiabetic effects of exenatide, empagliflozin, quercetin, and combination of the drugs in type 2 diabetic rats. Fundamental & clinical pharmacology 38 (3) (2023)
Yasemin Korkmaz, Burak Dik
The comparison of the antidiabetic effects of exenatide, empagliflozin, quercetin, and combination of the drugs in type 2 diabetic rats. Fundamental & clinical pharmacology (2023)